Clinical Trial Update: A Clinical Trial of the Safety, Pharmacokinetics and Hematologic Effects of Imatinib on Myelopoiesis in Adults When Given With and Without Isoniazid and Rifabutin [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating safety, pharmacokinetics, and hematologic effects of imatinib with and without isoniazid and rifabutin in adults with tubercul…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Tuberculosis

Drugs mentioned

• ISONIAZID (ISONIAZID)
• Imatinib (imatinib)
• RIFABUTIN (Rifabutin)

Snippet

Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) | Conditions: Tuberculosis | Phase 2 | Status: COMPLETED | Results posted: 2023-09-28